Glucolimpa
Glucolimpa is an antidiabetic agent used in adult patients with type 2 diabetes mellitus. It was FDA-approved in 2014. Empagliflozin can be used as a single agent or as a combination agent with other antidiabetic products. Combination products include empagliflozin and linagliptin and empagliflozin in combination with metformin. These newer agents can be more expensive for patients, thus impeding the clinician’s ability to prescribe them based on patient financial considerations. However, the American Diabetes Association (ADA) is calling for agents with proven mortality reduction for use as second-line therapy after metformin.
Cosar® pharmaceuticals as a well-known Iranian pioneer in pharmaceutical industry for over 50 years, has continuously developed products for children, adults and seniors to help them have a healthy quality life and increase life expectancy Our ultimate aim has been providing accessible healthcare products for people from all walks of life within and beyond the political borders.
Description of Glucolimpa
Glucolimpa
Glucolimpa
Empagliflozin works by inhibiting the sodium-glucose co-transporter-2 (SGLT-2) found in the proximal tubules in the kidneys. Through SGLT2 inhibition, empagliflozin reduces renal reabsorption of glucose and increases urinary excretion of glucose.
Type 2 diabetes mellitus
- Glucolimpa is used to treat type 2 diabetes in adult patients (aged 18 years and older) that cannot be controlled by diet and exercise alone.
- Glucolimpa can be used without other medicines in patients who cannot take metformin (another diabetes medicine).
- Glucolimpa can also be used with other medicines for the treatment of diabetes. These may be medicines taken by mouth or given by injection such as insulin. Glucolimpa works by blocking the SGLT2 protein in your kidneys. This causes blood sugar (glucose) to be removed in your urine. Thereby Glucolimpa lowers the amount of sugar in your blood. This medicine can also help prevent heart disease in patients with type 2 diabetes mellitus. It is important that you continue with your diet and exercise plan as told by your doctor, pharmacist or nurse.
Heart failure
- Glucolimpa is used to treat heart failure in adult patients with symptoms due to impaired heart function.
Empagliflozin is an oral medication dosed at either 10 mg daily or 25 mg daily. The recommended dose is 10 mg once daily in the morning, taken with or without food. If tolerated initially, dosing may increase up to 25 mg. Correct volume depletion, if present, before starting the drug.
Consult your physician or phrmacist before taking this product if you have a history of allergy to red fruits and rice, are pregnant or nursing, are under 18.
Keep out of reach and sight of children.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine